Skip to main content
OpenTrials

Clinical trial condition

Retinitis Pigmentosa

Explore clinical trials studying Retinitis Pigmentosa. Study availability and eligibility vary by location and protocol.

199 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Retinitis Pigmentosa trial results

Completed

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

NCT03073733

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Gavin Herbert Eye Inst, Univ Cal Irvine Irvine, California, United States
  • Retina-Vitreous Associates Medical Group Los Angeles, California, United States
  • Ophthalmic Consultants of Boston Boston, Massachusetts, United States
View Trial Details
Completed

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)

NCT02110225

Conditions
Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +6 more
Locations
  • Azienda Ospedaliero Universitaria Careggi Florence, Italy
  • Azienda Ospedaliera San Paolo - U.O. Oculistica Milan, Italy
  • A.O. Seconda Università Degli Studi di Napoli - Nuovo Policlinico - UOC Oftalmologia Naples, Italy
  • Università Cattolica del Sacro Cuore - Policlinico Gemelli - Istituto di Oftalmologia Rome, Italy
View Trial Details
Completed

Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]

NCT04945772

Conditions
Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +14 more
Locations
  • Nanoscope Clinical Site Beverly Hills, California, United States
  • Nanoscope Clinical Site Pensacola, Florida, United States
  • Nanoscope Clinical Site Fargo, North Dakota, United States
  • Nanoscope Clinical Site Houston, Texas, United States
View Trial Details
Completed

Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT

NCT05820100

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Nanoscope Clinical Site Phoenix, Arizona, United States
  • Nanoscope Clinical Site Beverly Hills, California, United States
  • Nanoscope Clinical Site Miami, Florida, United States
  • Nanoscope Clinical Site Fargo, North Dakota, United States
View Trial Details

Related conditions